Glucagon-like peptide-1 receptor agonist for primary prevention of hepatocellular carcinoma in high-risk patients: A real-world analysis across metabolic, viral, alcoholic, and hereditary liver disease.
Colton Jones, Jonathan Dao, Ariana N. Neely, Chidiebube Ugwu et autres
us (code pays fourni par la source)
0 citations
Journal of Clinical Oncology